People: Actelion Ltd (ATLN.VX)

ATLN.VX on Virt-X Level 1

118.20CHF
19 Dec 2014
Price Change (% chg)

CHF0.90 (+0.77%)
Prev Close
CHF117.30
Open
CHF119.00
Day's High
CHF119.50
Day's Low
CHF117.20
Volume
897,719
Avg. Vol
516,980
52-wk High
CHF119.50
52-wk Low
CHF72.55

Search Stocks

Braunstein, Guy 

Brief Biography

Dr. Guy Braunstein has been Member of the Management Board, Executive Vice President, Head of Clinical Development of Actelion Ltd since July 1, 2009. He served as Chief Medical Officer at MerckSerono. In addition, he held the position of Chief Medical Officer at Serono International. He had various executive positions at Astra, Glaxo-Wellcome, GSK, Fisons, Rhone Poulenc Rorer and Chiron. He holds a Doctor of Medicine and Doctorate in Philosophy degree in Life Science from Universite de Paris.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks